These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
398 related articles for article (PubMed ID: 6256275)
1. Niemann-Pick disease, Type C: evidence for the deficiency of an activating factor stimulating sphingomyelin and glucocerebroside degradation. Christomanou H Hoppe Seylers Z Physiol Chem; 1980 Oct; 361(10):1489-502. PubMed ID: 6256275 [TBL] [Abstract][Full Text] [Related]
2. Studies on the activation of sphingomyelinase activity in Niemann-Pick type A, B, and C fibroblasts: enzymological differentiation of types A and B. Poulos A; Ranieri E; Shankaran P; Callahan JW Pediatr Res; 1984 Nov; 18(11):1088-93. PubMed ID: 6096798 [TBL] [Abstract][Full Text] [Related]
3. Sphingomyelinase in cultured skin fibroblasts from normal and Niemann-Pick type C patients. Poulos A; Hudson N; Ranieri E Clin Genet; 1983 Oct; 24(4):225-33. PubMed ID: 6315279 [TBL] [Abstract][Full Text] [Related]
4. Clinical and biochemical diagnostics of Niemann-Pick disease. Maciejko D; Tylki-SzymaĆska A Klin Padiatr; 1986; 198(2):103-6. PubMed ID: 3009958 [TBL] [Abstract][Full Text] [Related]
5. Studies on sphingomyelinase and beta-glucosidase activities in Niemann-Pick disease variants. Phosphodiesterase activities measured with natural and artificial substrates. Besley GT; Moss SE Biochim Biophys Acta; 1983 Jun; 752(1):54-64. PubMed ID: 6303436 [TBL] [Abstract][Full Text] [Related]
7. Enzymatic hydrolysis of sphingomyelin liposomes by normal tissues and tissues from patients with Niemann-Pick disease. Poulos A; Shankaran P; Jones CS; Callahan JW Biochim Biophys Acta; 1983 May; 751(3):428-31. PubMed ID: 6303435 [TBL] [Abstract][Full Text] [Related]
8. A practical chromogenic procedure for the detection of homozygotes and heterozygous carriers of Niemann-Pick disease. Gal AE; Brady RO; Hibbert SR; Pentchev PG N Engl J Med; 1975 Sep; 293(13):632-6. PubMed ID: 239343 [TBL] [Abstract][Full Text] [Related]
9. Effects of dimethylsulfoxide on sphingomyelinase in cultured human fibroblasts and correction of sphingomyelinase deficiency in fibroblasts from Niemann-Pick patients. Sakuragawa N; Sato M; Yoshida Y; Kamo I; Arima M; Satoyoshi E Biochem Biophys Res Commun; 1985 Jan; 126(2):756-62. PubMed ID: 2983689 [TBL] [Abstract][Full Text] [Related]
10. Studies on the activation of the enzymatic hydrolysis of sphingomyelin liposomes. Poulos A; Ranieri E; Shankaran P; Callahan JW Biochim Biophys Acta; 1984 Apr; 793(2):141-8. PubMed ID: 6712963 [TBL] [Abstract][Full Text] [Related]
11. [Activators for sphingohydrolases and the nature of the sphingomyelinase deficiency in Niemann-Pick disease types A, B and C (author's transl)]. Baraton G; Revol A Clin Chim Acta; 1977 May; 76(3):339-43. PubMed ID: 192496 [TBL] [Abstract][Full Text] [Related]
12. Enzyme activities and phospholipid storage patterns in brain and spleen samples from Niemann-Pick disease variants: a comparison of neuropathic and non-neuropathic forms. Besley GT; Elleder M J Inherit Metab Dis; 1986; 9(1):59-71. PubMed ID: 3014212 [TBL] [Abstract][Full Text] [Related]
13. Studies on pyrophosphate diesterase activity in cultured human fibroblasts: a deficiency in Niemann-Pick disease. Besley GT; Moss SE Clin Chim Acta; 1981 Nov; 117(1):75-84. PubMed ID: 6277531 [TBL] [Abstract][Full Text] [Related]
14. Chromatofocusing of skin fibroblast sphingomyelinase: alterations in Niemann-Pick disease type C shared by GM1-gangliosidosis. Vanier MT; Rousson R; Louisot P Clin Chim Acta; 1983 May; 130(2):155-61. PubMed ID: 6307547 [TBL] [Abstract][Full Text] [Related]
15. Effects of dimethylsulfoxide on sphingomyelinase activities in normal and Niemann-Pick type A, B and C fibroblasts. Sato M; Yoshida Y; Sakuragawa N; Arima M Biochim Biophys Acta; 1988 Sep; 962(1):59-65. PubMed ID: 2843241 [TBL] [Abstract][Full Text] [Related]
16. Sphingomyelinase activity levels in human peripheral blood leukocytes, using [3H]sphingomyelin as substrate: study of heterozygotes and homozygotes for Niemann-Pick disease variants. Zitman D; Chazan S; Klibansky C Clin Chim Acta; 1978 May; 86(1):37-43. PubMed ID: 26487 [TBL] [Abstract][Full Text] [Related]
17. Niemann-Pick disease type B: prenatal diagnosis and enzymatic and chemical studies on fetal brain and liver. Wenger DA; Kudoh T; Sattler M; Palmieri M; Yudkoff M Am J Hum Genet; 1981 May; 33(3):337-44. PubMed ID: 6264784 [TBL] [Abstract][Full Text] [Related]
18. Correction of sphingomyelinase deficiency in Niemann-Pick type C fibroblasts by removal of lipoprotein fraction from culture media. Thomas GH; Tuck-Muller CM; Miller CS; Reynolds LW J Inherit Metab Dis; 1989; 12(2):139-51. PubMed ID: 2547109 [TBL] [Abstract][Full Text] [Related]
19. A profound deficiency of (CH3-14C)choline sphingomyelin-cleaving enzyme in Niemann-Pick disease type B. Orii T; Nakamura F; Kudoh T; Tsuchihashi K; Nakao T Tohoku J Exp Med; 1975 Oct; 117(2):193-5. PubMed ID: 174246 [TBL] [Abstract][Full Text] [Related]
20. Immunological studies on lysosomal sphingomyelinase: identification of a 28 000-Da component deficient in urine from patients with Niemann-Pick disease types A and B. Schram AW; Dreissen M; Bastiaannet J; Donker-Koopman WE; Brouwer-Kelder EM; Weitz G; Barranger JA; Sandhoff K; Tager JM Biosci Rep; 1984 Dec; 4(12):1051-7. PubMed ID: 6099155 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]